Compare Docusign Inc (DOCU) vs InMode Ltd (INMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Docusign Inc vs InMode Ltd — how do they compare? Docusign Inc trades at $71.08 (market cap $13.35B), while InMode Ltd trades at $14.21 (market cap $809.93M). The key difference: Docusign Inc is far larger — about 16.5× InMode Ltd's market cap, and Docusign Inc is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Docusign Inc for 71 Days and InMode Ltd for 28 Days on average.
| DOCU | INMD | |
|---|---|---|
Market Cap | $13.35B | $809.93M |
Volume | 3,158,858 | 365,490 |
Sector | Technology | Health |
52-Week High | $73.14 | $16.62 |
52-Week Low | $41.75 | $12.76 |
Typical Hold Time | 71 Days | 28 Days |
Enterprise Value | $12.76B | $313.27M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DOCU trades at $71.43, up 3.67% on the day, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $2.98B in 2025, with net income surging to $1.07B, though cash flow turned negative. The stock is supported by AI-driven IAM adoption and leadership in signing workflow software, as noted in recent news.
Outlook is mixed: growth from AI and market position offers upside, but high valuation (P/E 43.55), insider selling, and slowing revenue growth pose risks. Analyst consensus is cautious with a $68.75 target below current price, suggesting limited near-term gains amid competitive and execution challenges.
InMode (INMD) trades at $14.08, up 0.5% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 76.5% gross margins and 20.7% net income margin, though Q1 2026 earnings missed expectations. Recent developments include the launch of Morpheus8 Cool technology and an unsolicited acquisition offer from Steel Partners at $16.75 per share in July 2026.
Investment outlook is cautiously optimistic with attractive valuation metrics (P/E 11.6, EV/EBITDA 4.5) offset by near-term revenue stagnation. Key risks include US platform sales decline and management capital allocation concerns. Analyst consensus leans neutral with 45% buy ratings and 55% hold, suggesting potential upside if the acquisition materializes or international growth accelerates.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →
